4 options
Breakthrough business models : drug development for rare and neglected diseases and individualized therapies : workshop summary / Theresa Wizemann, Sally Robinson, and Robert Giffin ; Forum on Health Sciences Policy, Institute of Medicine of the National Academies.
- Format:
- Book
- Language:
- English
- Subjects (All):
- Orphan drugs--Government policy--United States.
- Orphan drugs.
- Pharmaceutical policy--United States.
- Pharmaceutical policy.
- Drugs--Design--United States.
- Drugs.
- Physical Description:
- 1 online resource (149 p.)
- Edition:
- 1st ed.
- Place of Publication:
- Washington, D.C. : National Academies Press, 2009.
- Language Note:
- English
- Summary:
- "The Institute of Medicine's Forum on Drug Discovery, Development, and Translation held a public workshop on June 23, 2008, titled "Breakthrough Business Models: Drug Development for Rare and Neglected Diseases and Individualized Therapies." The purpose of the workshop was to explore innovative strategies for orphan drug development."--P. 3.
- Contents:
- Introduction and overview
- Current model for financing drug development : from concept through approval
- The Food and Drug Administration's Orphan Drug Program
- Diverse funding models
- Strategies for facilitating sharing of research materials and data
- Strategies of navigation intellectual property
- Strategies for facilitating clinical trials
- Summary.
- Notes:
- Bibliographic Level Mode of Issuance: Monograph
- Includes bibliographical references (p. 104-105).
- ISBN:
- 9786612083556
- 9780309178167
- 0309178169
- 9781282083554
- 1282083554
- 9780309120890
- 0309120896
- OCLC:
- 726823396
The Penn Libraries is committed to describing library materials using current, accurate, and responsible language. If you discover outdated or inaccurate language, please fill out this feedback form to report it and suggest alternative language.